Abstract
Investigating associations between metabolites and late midlife cognitive function could reveal potential markers and mechanistic insights relevant to early dementia. Here, we aimed to systematically explore the metabolic underpinnings of cognitive outcomes across the 7th decade of life, while untangling influencing life course factors. Using levels of 1019 metabolites detected by liquid chromatography-mass spectrometry and quantified at age 60-64, we evaluated relationships between metabolites and cognitive outcomes in the British 1946 Birth Cohort (N=1740). We conducted pathway and network analyses to allow for greater insight into underlying mechanisms, and sequentially adjusted for life course factors including social factors, childhood cognition and lifestyle influences. After adjusting for multiple tests, 155 metabolites, 10 pathways and 5 network modules demonstrated relationships with cognitive outcomes. Integrating these, we identified thirty-five “hub” metabolites that were influential in their module and associated with our outcomes. Notably, we report relationships between a module comprised of acylcarnitines and processing speed that were independent of life course factors, revealing palmitoylcarnitine as a hub (final model: ß =-0.10, 95%CI =-0.15--0.052, p=5.99×10−5). Two modules additionally demonstrated associations with several cognitive outcomes that were partly explained by life course factors: one enriched in nucleosides and amino acids, and another in vitamin A and C metabolites. Our other findings, including a module enriched in sphingolipid pathways, were entirely explained by life course factors - particularly social factors and childhood cognition. These results highlight potential metabolic mechanisms underlying cognitive function in late midlife, suggesting marker candidates and life course relationships for further study.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This paper represents independent research part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. This work was further supported by the UK Medical Research Council which provides core funding for the MRC National Survey of Health and Development (MC_UU_12019/06).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study obtained ethical approval from Greater Manchester Local Research Ethics Committee and the Scotland Research Ethics committee. Research was conducted in accordance with the Declaration of Helsinki and all participants provided written informed consent at each wave.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Manuscript updated with reduced words, supplemental files updated.
Data Availability
Data are stored and held by the MRC Unit of Lifelong Health & Ageing, UCL. Requests for data can be made by contacting the unit directly.
